메뉴 건너뛰기
Diabetes Care
Volumn 35, Issue 3, 2012, Pages
Metformin-induced hepatotoxicity
Author keywords

[No Author keywords available]
Indexed keywords

METFORMIN;
EID: 84859027311     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2306     Document Type: Letter
Times cited : (47)
References (5)
  • 1
    • 77957674134 scopus 로고    scopus 로고
    • Hepatotoxicity associated withmetformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease
    • Cone CJ, Bachyrycz AM, Murata GH. Hepatotoxicity associated withmetformin therapy in treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease. Ann Pharmacother 2010;44:1655-1659
    • (2010) Ann Pharmacother , vol.44 , pp. 1655-1659
    • Cone, C.J.1    Bachyrycz, A.M.2    Murata, G.H.3
  • 2
    • 0027362542 scopus 로고
    • Causality assessment of adverse reactions to drugs - I: A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
    • DOI 10.1016/0895-4356(93)90101-6
    • Danan G, Benichou C. Causality assessment of adverse reactions to drugs - I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-1330 (Pubitemid 23333873)
    • (1993) Journal of Clinical Epidemiology , vol.46 , Issue.11 , pp. 1323-1330
    • Danan, G.1    Benichou, C.2
  • 3
    • 72549104493 scopus 로고    scopus 로고
    • Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin
    • Spanish Treatment ofResistance to Insulin in Hepatitis C Genotype 1 Group
    • Romero-Gómez M, Diago M, Andrade RJ, et al.; Spanish Treatment ofResistance to Insulin in Hepatitis C Genotype 1 Group. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin. Hepatology 2009; 50:1702-1708
    • (2009) Hepatology , vol.50 , pp. 1702-1708
    • Romero-Gómez, M.1    Diago, M.2    Andrade, R.J.3
  • 4
    • 77955293255 scopus 로고    scopus 로고
    • Clarifying metformin's role and risks in liver dysfunction
    • Brackett CC. Clarifying metformin's role and risks in liver dysfunction. J Am Pharm Assoc (2003) 2010;50:407-410
    • (2010) J Am Pharm Assoc (2003) , vol.50 , pp. 407-410
    • Brackett, C.C.1
  • 5
    • 74249111367 scopus 로고    scopus 로고
    • Many Americans have pre-diabetes and should be considered for metformin therapy
    • Rhee MK, Herrick K, Ziemer DC, et al. Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2010;33:49-54
    • (2010) Diabetes Care , vol.33 , pp. 49-54
    • Rhee, M.K.1    Herrick, K.2    Ziemer, D.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.